149 related articles for article (PubMed ID: 22032007)
1. [Say no to the extremes in the debate on lipid reduction].
Hjemdahl P; Allhammar A; Eklund J; Forslund T; Hulting J; Kahan T; Martinsson A; Malmström R; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B
Lakartidningen; 2011 Sep 7-13; 108(36):1664-5. PubMed ID: 22032007
[No Abstract] [Full Text] [Related]
2. [Target levels for LDL cholesterol are put out of the running. Cholesterol should be lowered maximally in high cardiovascular risk].
Olsson AG
Lakartidningen; 2011 Jun 1-14; 108(22-23):1240-3. PubMed ID: 21786498
[No Abstract] [Full Text] [Related]
3. [Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value].
MMW Fortschr Med; 2007 Apr; 149(17):56-7. PubMed ID: 17674912
[No Abstract] [Full Text] [Related]
4. Is intensive LDL-cholesterol lowering beneficial and safe?
Cheung BM; Lam KS
Lancet; 2010 Nov; 376(9753):1622-4. PubMed ID: 21067806
[No Abstract] [Full Text] [Related]
5. Improve-it: Full disclosures?
Nicot P; Guerbaai RA; Ennezat PV
Int J Cardiol; 2015 Dec; 201():380-1. PubMed ID: 26310982
[No Abstract] [Full Text] [Related]
6. [Strengthened support for statin therapy as secondary prevention. Doubtful evidence for more intensive lowering of cholesterol levels].
Håkansson J
Lakartidningen; 2011 Jun 1-14; 108(22-23):1234-5. PubMed ID: 21786497
[No Abstract] [Full Text] [Related]
7. [Statins plus cholesterol resorption inhibitor. LDL goal values attainable].
MMW Fortschr Med; 2002 Sep; 144(38):56. PubMed ID: 12395708
[No Abstract] [Full Text] [Related]
8. [SBU should investigate what is an evidence-based and cost-effective use of statins].
Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B
Lakartidningen; 2009 Aug 5-18; 106(32-33):1992-4. PubMed ID: 19764381
[No Abstract] [Full Text] [Related]
9. [Controlling LDL cholesterol from 2 sides. "I have never seen such low LDL values"].
MMW Fortschr Med; 2003 May; 145(20):59. PubMed ID: 12822234
[No Abstract] [Full Text] [Related]
10. [Sequelae of the CARDS Study. LDL of 110 mg/dl still too high?].
Klose G
MMW Fortschr Med; 2004 Jun; 146(26):14. PubMed ID: 15529683
[No Abstract] [Full Text] [Related]
11. [Cholesterol goals are now easier to reach. Half LDL cholesterol with only one tablet daily].
MMW Fortschr Med; 2005 Nov; 147(45):55. PubMed ID: 16320656
[No Abstract] [Full Text] [Related]
12. [Dual inhibition of cholesterol using the drug combination ezetimibe/simvastatin?].
Vaverková H
Vnitr Lek; 2007 Apr; 53(4):421-7. PubMed ID: 17578178
[TBL] [Abstract][Full Text] [Related]
13. [The discussion on target goals in lipid reduction is still going on. The Expert Committee--a block for current cardiovascular prevention].
Olsson AG
Lakartidningen; 2011 Nov 23-29; 108(47):2442-3. PubMed ID: 22468387
[No Abstract] [Full Text] [Related]
14. [For coronary disease patients is certain: the lower the LDL the better].
MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
[No Abstract] [Full Text] [Related]
15. Begin with the real-world patients of non-goal-achieved hypercholesterolemia in taiwan through the ezetimibe/simvastatin tablet - The BRAVO Study.
Huang JC; Lee TY; Liou MJ; Lin CM; Pei D; Chen ZC; Liu RT; Kwok CF
Curr Med Res Opin; 2011 Aug; 27(8):1645-51. PubMed ID: 21699369
[TBL] [Abstract][Full Text] [Related]
16. [Considerable LDL lowering is advantageous].
MMW Fortschr Med; 2005 Sep; 147(35-36):9. PubMed ID: 16180563
[No Abstract] [Full Text] [Related]
17. [CARDS confirms usefulness of LDL lowering in type 2 diabetics].
Bern VH
Praxis (Bern 1994); 2004 Oct; 93(44):1 p following 1830. PubMed ID: 15559908
[No Abstract] [Full Text] [Related]
18. [On the current debate on lowering LDL cholesterol with ezetimibe].
Breuer HW
Dtsch Med Wochenschr; 2010 Nov; 135(44):2201; author reply 2202. PubMed ID: 20979008
[No Abstract] [Full Text] [Related]
19. [How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition].
MMW Fortschr Med; 2005 Nov; 147(45):54. PubMed ID: 16320655
[No Abstract] [Full Text] [Related]
20. Lack of evidence for recommended low-density lipoprotein cholesterol treatment targets.
Modest GA
Ann Intern Med; 2007 Apr; 146(8):614; author reply 614-5. PubMed ID: 17438326
[No Abstract] [Full Text] [Related]
[Next] [New Search]
